As the roll out of coronavirus (COVID-19) vaccines begins, this policy brief asks how to ensure vaccines for all. In doing so, it examines the case for multilateral approaches to access and delivery, maps key challenges, and identifies priority actions for policy makers. The absence of a comprehensive approach to ensure vaccine access in developing countries threatens to prolong the pandemic, escalating inequalities and delaying the global economic recovery. While new collaborative efforts such as ACT Accelerator and its COVAX initiative are helping to bridge current gaps, these are not enough in circumstances where demand far outstrips supply. Based on the current trajectory, mass immunisation efforts for poorer countries could be delayed until 2024 or beyond, prolonging human and economic suffering for all countries. Policy actions to support equitable vaccine access in developing countries include: (i) supporting multilateral frameworks for equitable allocation of vaccines and for crisis response, resilience and prevention; (ii) highlighting the role of development finance; and, (iii) promoting context-driven solutions.
Coronavirus (COVID‑19) vaccines for developing countries: An equal shot at recovery
Policy paper
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Policy paper11 October 202241 Pages
-
4 October 202212 Pages
-
Policy paper30 August 202227 Pages
-
21 April 202225 Pages
-
4 April 202224 Pages
-
Policy paper17 March 202257 Pages
-
Policy paper17 March 202216 Pages
Related publications
-
21 April 2026127 Pages